However Professor Invoice Bowtell, a strategic well being coverage marketing consultant with the College of NSW, mentioned the federal authorities had relied too closely on AstraZeneca.
“We’re right here as a result of a 12 months in the past the Australian authorities, with eyes huge open, rejected the logical factor to do, which was to again each horse within the race,” Professor Bowtell mentioned.
“Now, we’re in a really severe place and it’s essentially as a result of they made appalling choices a 12 months in the past that stopped us having extra provide of Pfizer and Moderna.”
Professor Bowtell, an architect of Australia’s response to the HIV AIDS disaster, is among the many most vocal critics of the vaccine rollout.
“We’re significantly behind each comparable nation internationally as a result of we should always have been funding manufacturing and investing in mRNA vaccines final 12 months,” he mentioned mentioning solely 3 per cent of Australia’s grownup inhabitants was absolutely vaccinated towards COVID-19 in comparison with greater than 50 per cent in Israel and about 45 per cent in Britain and the US.
Proof is more and more pointing to mRNA coronavirus vaccines, resembling Pfizer and Moderna, being a lot simpler to reconfigure to cowl rising and extremely infectious variants of coronavirus than extra standard kinds of inoculations resembling AstraZeneca.
However mRNA vaccines had by no means been utilized in people earlier than the coronavirus pandemic and Professor Danchin, who’s a non-voting member on the Australian Technical Advisory Group on Immunisation that advises the federal government on vaccines, mentioned well being officers had proven “acceptable warning” by ready till outcomes from scientific trials flowed in.
“There was a hesitancy to financial institution utterly on Pfizer and Moderna as a result of they have been a bit unknown,” she mentioned. “I don’t suppose anybody might have anticipated simply how efficient they’ve proven to be.”
Australian Medical Affiliation president Omar Khorshid believes the federal government made the precise name to spend money on two worldwide vaccines: Pfizer and Novax, alongside two domestically manufactured within the AstraZeneca and the College of Queensland’s the molecular clamp vaccine, which failed throughout scientific trials.
“Even with the advantage of hindsight, it was a fairly good and regarded determination,” Dr Khorshid mentioned.
“In the event you take a look at the place we might have been if we didn’t have any native manufacturing of vaccines, it’s arduous to know. AstraZeneca has underpinned the majority of our program and the truth that 65 per cent of our higher 70s are at the least partially shielded from COVID.”
Former secretary of the Commonwealth Division of Well being Professor Stephen Duckett mentioned Australia’s vaccine program was doomed from the beginning as a result of it had restricted itself to a slim of vary of vaccines, leaving the nation largely unvaccinated and weak to harmful COVID-19 outbreaks.
“It was the improper selection again then and it’s much more clearly the improper selection now, and we’re reaping the results of that,” Professor Duckett mentioned.
“We have been a lot, rather more slim in our funding choices than virtually each different superior financial system on this planet. Different nations hedged their bets throughout six, seven or eight vaccines, however we solely selected 4.”
Professor Duckett, who had his first dose of AstraZeneca not too long ago, mentioned he wouldn’t hesitate to ebook in his second shot in a couple of weeks time.
However he mentioned many individuals within the over 60s age group had misplaced confidence within the vaccine as a result of severe however uncommon facet impact, regardless of AstraZeneca being extremely efficient at stopping illness.
“We actually should get vaccination charges up amongst folks over 60 as much as the 95 p.c stage,” Professor Duckett mentioned. “That’s crucial, however realistically that may not occur till extra Pfizer is out there.”
Whereas Dr Khorshid acknowledged that had the federal government acted extra rapidly it could have secured “an enormous quantity of Pfizer early on”, he mentioned deliberations in regards to the vaccines occurred in a local weather of serious constraints on worldwide provides globally.
The primary batch of three.3 million doses of AstraZeneca allotted for Australia from Europe by no means arrived, setting the rollout again by a number of weeks, and fuelling issues different doses from abroad would even be stalled.
Dr Khorshid mentioned his largest concern in coming months was making certain Australians who had their first dose of the AstraZeneca vaccine booked in for his or her second shot.
He mentioned it was crucial Australia completed its vaccine rollout of AstraZeneca for the hundreds of thousands of Australians who had already had their first dose.
“We are able to’t let this uncertainty undermine the rollout additional,” he mentioned. “The second dose of AstraZeneca is crucial for immunity and for anybody who has uncovered themselves to the primary dose having the second shot is extraordinarily secure.”
“From a scientific viewpoint, it’s an absolute no-brainer. All people who has their first dose of AstraZeneca whether or not you’re 20 or 90, ought to have their second for full safety towards the virus.”
Federal Well being Minister Greg Hunt mentioned final month issues over delays in vaccine vials meant home manufacturing of AstraZeneca had been a “elementary element” of Australia’s immunisation technique.
“We foresaw what occurred in Europe and North America,” Mr Hunt mentioned. “With out ever figuring out what can be the precise end result, we might see vaccine nationalism, worldwide provide chain challenges, nations withholding vaccines.”
A spokeswoman for AstraZeneca mentioned the corporate had no plans to halt manufacturing following the announcement the vaccine can be phased out in Australia.
“We’re dedicated to fulfilling our contract with the Australian Authorities,” she mentioned.
“The AstraZeneca vaccine helps to save lots of tens of hundreds of lives and forestall tons of of hundreds of hospitalisations attributable to COVID-19 and in depth information from scientific trials and real-world proof from hundreds of thousands of individuals exhibits that our vaccine is extremely efficient towards all types of the illness.”
Keep throughout probably the most essential developments associated to the pandemic with the Coronavirus Replace. Sign up to receive the weekly newsletter.